COMPOSITIONS AND METHODS FOR ASSAY MEASUREMENTS

    公开(公告)号:US20230279290A1

    公开(公告)日:2023-09-07

    申请号:US18145735

    申请日:2022-12-22

    CPC classification number: C09K11/02 C12Q1/6816

    Abstract: The disclosure relates to novel compositions comprising an electrochemiluminescence (ECL) co-reactant. In embodiments, the composition further comprises an ionic component, a surfactant, or combination thereof. In embodiments, the ECL co-reactant is triethanolamine (TEA), tert-butyldiethanolamine (tBDEA), methyldibutylethanolamine (MDEA), 3-[Bis-(2-hydroxy-ethyl)-amino]-propane-1-sulfonic acid (DEA-PS), or a combination thereof. Methods of using the compositions and kits comprising the compositions are also provided herein, including methods using ECL-labeled oligonucleotide probes having quenching moieties.

    DEVICE HOUSING WITH LIGHTING
    13.
    发明申请

    公开(公告)号:US20230070700A1

    公开(公告)日:2023-03-09

    申请号:US17986182

    申请日:2022-11-14

    Abstract: The application is directed to a device housing. The device housing includes a first light device, the first light device including a first electrical supply configured to provide an electrical signal to a first light emitting diode (LED), the first LED separated from a first surface of a diffuser film by a space, wherein the diffuser film includes a second surface, opposite the first surface, the second surface configured to contact a first light pipe.

    METHODS AND KITS FOR DETECTING AUTOIMMUNE DISEASES

    公开(公告)号:US20230021837A1

    公开(公告)日:2023-01-26

    申请号:US17779900

    申请日:2020-11-25

    Abstract: The invention relates to assay methods and kits for assessing autoimmune diseases in a human subject. In embodiments, the present disclosure provides assay methods and kits for diagnosing a subject with or predicting that a subject will develop Type 1 diabetes. In embodiments, the present disclosure provides assay methods and kits for assessing responsiveness of a subject having Type 1 diabetes to treatment with alefacept. In embodiments, the present disclosure provides assay methods and kits for diagnosing a subject with systemic lupus erythematosus. In embodiments, the present disclosure provides assay methods and kits for determining if a subject is at risk of a systemic lupus erythematosus flare. In embodiments, the present disclosure provides assay methods and kits for diagnosing a subject with celiac disease.

    MULTI-PLEX ASSAY PLATES AND METHODS OF MAKING

    公开(公告)号:US20220341923A1

    公开(公告)日:2022-10-27

    申请号:US17728292

    申请日:2022-04-25

    Abstract: Described herein is a method of preparing a bifunctional assay surface. In particular, a method is provided for preparing an assay surface that includes a primary reagent and a secondary reagent. In one aspect, the primary and secondary reagents are immobilized on the assay surface by different surface chemistries. In one aspect, a method is provided for preparing an assay surface that includes a proteinaceous primary reagent and a thiol-containing secondary reagent. In one aspect, a method is provided for preparing an assay surface that includes a capture-target hybrid and a thiol-containing secondary reagent.

    ASSAY SYSTEM CALIBRATION SYSTEMS AND METHODS

    公开(公告)号:US20220221449A1

    公开(公告)日:2022-07-14

    申请号:US17572280

    申请日:2022-01-10

    Abstract: Systems and methods for calibrating sample assays are provided. Systems may include assay devices and components for carrying out calibration and sample assays. Systems may further include processing components and storage units configured for receiving calibration information, determining calibration models and parameters, and applying calibration parameters to sample data. Systems may further include components for operating in a networked environment. Methods may include techniques and processes for carrying out calibration and sample assays, determining calibration models and parameters, and applying calibration parameters to sample data.

Patent Agency Ranking